FTUS
TLSIW icon

Flow Traders U.S.’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Flow Traders U.S.’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,255
Closed -$1K – 1171
2023
Q2 		$1K Buy
17,255
+6,850
+66% +$465 ﹤0.01% 803
2023
Q1 		$1K Buy
+10,405
New +$918 ﹤0.01% 838

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Flow Traders U.S.'s TLSIW Position: Q3 2023 in Review

Flow Traders U.S. sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2023, closing a stake of 17,255 shares — an estimated $1K sold.

Flow Traders U.S. first reported a position in TLSIW in Q1 2023 and held it in 2 quarters. The position peaked at $1K in Q2 2023. 19 funds tracked by Wall St. Rank hold TLSIW as of Q3 2023.

  • Flow Traders U.S. reported no remaining TriSalus Life Sciences Warrant position as of Q3 2023 after selling out during the quarter.
  • Flow Traders U.S. sold 17,255 TriSalus Life Sciences Warrant shares in Q3 2023, an estimated $1K.
  • Flow Traders U.S. first reported a position in TriSalus Life Sciences Warrant in Q1 2023 and held it in 2 quarters.
  • Flow Traders U.S.'s TriSalus Life Sciences Warrant position peaked at $1K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2023.

Based on Flow Traders U.S.'s 13F filing for Q3 2023, filed 14 Nov 2023.